North America Hair Loss Treatment Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the North America hair loss treatment products market size was valued at USD 1.05 billion in 2025 and estimated to grow from USD 1.13 billion in 2026 to reach USD 1.59 billion by 2031, at a CAGR of 7.15% during the forecast period (2026-2031).

This report is Segmented by Product Type (Shampoos and Conditioners, Serums, Others), Gender (Male, Female), Category (Topical, Oral), Distribution Channel (Supermarkets/Hypermarkets, Health and Beauty Stores, Online Retail Stores, and More), and Geography (United States, Canada, Mexico, Rest of North America). The Market Forecasts are Provided in Terms of Value (USD).

North America Hair Loss Treatment Products Market Trends and Insights

Aging demographics and androgenetic alopecia prevalence drive market foundation

North America's demographic shifts are creating a sustained demand for hair loss treatments as cases of androgenetic alopecia continue to rise. According to the National Alopecia Areata Foundation, approximately 700,000 individuals in the U.S. are affected by some form of alopecia areata. The aging population, particularly the large Baby Boomer demographic, is driving increased treatment adoption. The rise in diagnosed cases and growing awareness of available treatments are fostering innovation and market growth for hair loss solutions. The U.S. Census Bureau reports that the population aged 65 and older in the U.S. grew by 3.1% in 2025, reaching 61.2 million. Since the prevalence of androgenetic alopecia increases with age, this demographic trend ensures consistent market growth, largely unaffected by economic fluctuations. Hair loss, as a progressive condition, requires long-term treatment adherence. In Mexico, the expansion of healthcare infrastructure, supported by COFEPRIS's regulatory modernization, is improving access to both prescription and over-the-counter treatments, particularly for aging populations that previously lacked specialized dermatological care.

Social media amplifies treatment adoption among younger demographics

Social media platforms such as Instagram, TikTok, YouTube, and Facebook are filled with personal stories and testimonials about hair loss and treatment experiences. These narratives strongly connect with younger audiences, motivating them to try advertised products and therapies. Digital platforms, particularly TikTok, are transforming how individuals discover and adopt hair loss treatments, with TikTok emerging as the leading health and beauty e-retailer in the U.S. Influencers and celebrities sharing their hair care routines, transformations, or hair loss treatments create viral trends that increase awareness and normalize treatment adoption. Their endorsements significantly influence product preferences and purchasing decisions among younger consumers. Social media acts as a discovery platform where younger users regularly come across new products, treatment options, and promotional offers, expediting their consideration and purchase decisions. Internet and social media usage is widespread in the region, with 93% of the U.S. population using the internet in 2023, according to the World Bank. However, while social media helps popularize treatments, it also spreads unverified claims and misinformation. This dual effect can spark curiosity and experimentation but also cause confusion, highlighting the need for evidence-based marketing.

Counterfeit product proliferation undermines consumer confidence

The FDA issued multiple warnings throughout 2024-2025 regarding unapproved hair loss products, including specific alerts about compounded topical finasteride formulations linked to adverse effects. Regulatory enforcement actions have significantly intensified as counterfeit products exploit consumer vulnerabilities, including desperation for effective treatments and restricted access to prescriptions. This issue is especially prevalent in online marketplaces, where verification mechanisms are often insufficient to ensure product authenticity. The widespread availability of unregulated formulations presents a dual threat, as these products not only risk being ineffective but may also pose serious safety concerns. Some of these formulations have been found to contain undisclosed pharmaceutical ingredients or harmful adulterants, further endangering consumers. In Mexico, COFEPRIS has enhanced its oversight of cosmetic establishments by enforcing stricter verification requirements under NOM-259 Good Manufacturing Practices, which became effective in July 2023. Additionally, COFEPRIS has introduced simplified procedures to facilitate the approval of legitimate health supplies. Consumer education campaigns continue to stress the importance of using FDA-approved treatments and consulting licensed healthcare providers. However, misinformation on social media remains a significant challenge, as it promotes unverified remedies and potentially hazardous DIY formulations, further complicating efforts to ensure consumer safety.

Other drivers and restraints analyzed in the detailed report include:

1. Technological innovation expands treatment efficacy and patient access
2. At-home treatment expansion democratizes access and reduces costs
3. Healthcare infrastructure gaps limit treatment access

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Shampoos and conditioners hold a dominant 82.62% share of the North American hair loss treatment market in 2025, highlighting consumers' preference for these well-known, daily-use products. These items benefit from extensive retail availability across supermarkets, pharmacies, and e-commerce platforms, enabling broad market penetration without requiring prescriptions or specialized consultations. On the other hand, serums are the fastest-growing segment, with a 7.44% CAGR projected through 2031. Their growth is driven by premium brand positioning and the inclusion of clinical-grade ingredients that support higher pricing. Furthermore, the growing "skinification" trend in hair care has raised consumer expectations for precise, effective formulations, presented in elegant packaging similar to facial serums.

At the same time, the "Others" category, which includes supplements, devices, and professional treatments, leverages innovations from adjacent markets such as nutraceuticals and medical devices. However, the regulatory environment varies significantly: shampoos are regulated as cosmetics, while serums containing pharmaceutical ingredients must follow drug approval processes. This regulatory complexity provides established players with expertise in compliance a competitive edge.

Female consumers hold a significant 72.20% market share in 2025, driven by increasing societal acceptance of hair care investments and a diverse range of products, from cosmetics to medical-grade treatments. Women's hair loss often appears as diffuse thinning rather than traditional pattern baldness, fueling demand for volumizing shampoos, scalp treatments, and hormonal therapies such as spironolactone and topical antiandrogens. Meanwhile, the male segment is growing rapidly, with an 7.98% CAGR projected through 2031, supported by decreasing stigmas and targeted marketing efforts addressing the psychological effects of androgenetic alopecia.

Rogaine's "National Hats Off Day" campaign exemplifies effective male consumer engagement. Additionally, ethnic differences in treatment perceptions highlight opportunities for market segmentation, indicating that culturally tailored strategies could accelerate adoption. Male-focused direct-to-consumer platforms like Hims and Roman have simplified prescription access through telemedicine. Moreover, the approval of JAK inhibitors introduces new options for severe cases that were previously limited to hair transplantation. The combination of social media influence, clinical advancements, and reduced access barriers positions the male segment for sustained growth, despite its smaller current market base.

Complete Report Scope:

• By Product Type
  • Shampoos and Conditioners
  • Serums
  • Others
• By Gender
  • Male
  • Female
• By Category
  • Topical
  • Oral
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Health and Beauty Stores
  • Online Retail Stores
  • Other Distribution Channel
• By Geography
  • United States
  • Canada
  • Mexico
  • Rest of North America

List of Companies Covered in this Report:

1. Procter and Gamble Co.
2. Unilever PLC
3. L'Oreal S.A.
4. Kenvue
5. Natura and Co Holding S.A.
6. Church and Dwight Co., Inc.
7. Amway Corp
8. GNC Holdings, LLC
9. Coty Inc.
10. Back of Bottle
11. Pierre Fabre Group
12. Harklinikken
13. InVite Health
14. Codeage LLC
15. Viva Naturals
16. Back of Bottle
17. Pierre Fabre Group
18. KLAIRE LABS
19. Hair La Vie
20. Fleuria Beauty

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support